Kiniksa Pharmaceuticals, Ltd. (38) | Intellectual Property (3)
Browse by Subcategory
Recent Contracts
-
Exclusive License Agreement, dated as of November 1, 2013, by and between The Beth Israel Deaconess Medical Center and Primatope Therapeutics Inc
(Filed With SEC on February 24, 2022)
-
Amendments Nos. 1 and 2 to the License Agreement, dated September 25, 2017, by and between Kiniksa Pharmaceuticals and Regeneron Pharmaceuticals, Inc
(Filed With SEC on May 6, 2021)
-
Amendment No. 1 to the License Agreement, effective as of July 9, 2020, by and between Kiniksa Pharmaceuticals, Ltd. and MedImmune Limited
(Filed With SEC on July 15, 2020)
